Stock Forecast Chart
Stock Price Prediction Summary
Forecast Score Based on 2 Weeks
Based on our forecast, the price of MRVI will rise by +16.79% over the next 2 Weeks and hit $4.16 by Tuesday, May 12, 2026. In that time frame, MRVI's share price is expected to range between $4.00 and $4.32.
BearishAverageBullish| Date | Predicted Lower | Predicted | Predicted Upper |
|---|---|---|---|
| May 12, 2026 | 4.00 | 4.16 | 4.32 |
| May 11, 2026 | 3.99 | 4.14 | 4.28 |
| May 8, 2026 | 3.80 | 3.92 | 4.06 |
| May 7, 2026 | 3.80 | 3.94 | 4.07 |
| May 6, 2026 | 3.87 | 3.99 | 4.12 |
| May 5, 2026 | 3.77 | 3.89 | 4.01 |
| May 4, 2026 | 3.76 | 3.87 | 3.98 |
| May 1, 2026 | 3.55 | 3.66 | 3.76 |
| Apr 30, 2026 | 3.56 | 3.67 | 3.78 |
| Apr 29, 2026 | 3.62 | 3.73 | 3.83 |
MRVI shares rose +0.70% in Wednesday, April 29, 2026's trading session, rising from a previous close of $3.56 to move at $3.59. The stock demonstrated notable intraday movement (see MRVI's key stats for a full breakdown), fluctuating between $3.49 and $3.62, a +3.73% trading range. While recent weeks have seen some volatility, MRVI has managed to secure a +17.16% gain over the past 2 weeks. The upward price movement was accompanied by decreased trading volume, with approximately 950.54K shares changing hands, 638.36K fewer than the previous session. This amounted to $3.41M in total market activity.
Will MRVI Continue Its Upward Trend?
According to analyst ratings and projections for MRVI, Maravai LifeSciences Holdings, Inc. shares are anticipated to increase by +16.99%, potentially reaching $4.32 per share by May 12, 2026. Short-term technical indicators currently suggest a neutral sentiment for MRVI. For deeper insights, view our sentiment analysis on AAPL covering social and institutional perspectives. However, the stock has recorded 14 positive trading days within the past 30 sessions. Based on the MRVI stock forecast, now is a good time to buy MRVI stock because its current trading price is -13.77% below our predicted value, hinting at a possible overvaluation. For deeper insights, view our sentiment analysis on MRVI covering social and institutional perspectives.
MRVI Technical Momentum: Overbought, Oversold, or Neutral?
An analysis of Relative Strength Index (RSI) indicators provides insight into MRVI's momentum. Short-term RSIs (9, 14, and 20-day figures ranging from 57.08% to 59.52%) suggest the stock is in a neutral to slightly bearish momentum phase. The 50-day RSI, at 53.11%, suggests a neutral medium-term outlook. Additionally, the 100-day RSI, at 51.13%, maintains a neutral outlook for the long term. Insights into MRVI's shareholder base show how institutional investors are positioning themselves during these momentum shifts
Maravai LifeSciences Short-Term Forecasts
MRVI Forecast For Next 5 Days
Our algorithm anticipates Maravai LifeSciences (MRVI) stock could hit $3.11 by May 06, 2026. This represents a -13.36% fall from today's price, following a -4.82% change over the past five days.
MRVI Forecast For Next 30 Days
Based on analysis of market trends, the outlook for Maravai LifeSciences Holdings, Inc. (MRVI) stock over the next 30 days is largely negative. Price forecasts suggest an average target of $3.27, which would mean a -8.79% decrease from the current price of $3.59. Projections for this period range from a high of $3.89 to a low of $2.75.
MRVI Forecast For Next 90 Days
Our proprietary market analysis suggests predictions for Maravai LifeSciences's price over the next three months point to a rise. MRVI stock is expected to peak at $10.02 on Jul 29, 2026 after potentially dipping to $7.07 on Jul 08, 2026. On average, MRVI is likely to trade around $8.57 in the coming 90 days.
Maravai LifeSciences Stock Forecast 2025
Based on our predictive models, Maravai LifeSciences (MRVI) is expected to trade between $7.07 and $15.91 throughout 2026. This would result in an average price of $10.73, potentially offering investors a +199.30% return from current levels.
Maravai LifeSciences Holdings, Inc. Monthly Forecast 2026–2027
April 2026
According to our latest forecast models, Maravai LifeSciences Holdings, Inc. (MRVI) is positioned to show a strong performance in April 2026. The price is predicted to move between $7.72 and $8.16, settling at an average of $7.97. This could translate to a +122.32% gain.
May 2026
Based on current market signals, Maravai LifeSciences Holdings, Inc. is projected to trend may 2026. We forecast a trading range from $7.92 to $9.65, with a likely average price of $8.90. Investors could expect a potential return of +148.26%.
June 2026
Our predictive algorithms indicate Maravai LifeSciences Holdings, Inc. stock may see a shift in June 2026. The expected range spans $7.47–$9.68, with an average target of $8.62. This represents a positive outlook and a possible gain of +140.45%.
July 2026
Analyzing established trends, Maravai LifeSciences Holdings, Inc. looks set to move in July 2026. Projections place the stock between $7.07 and $10.43, averaging around $8.39. This suggests a +134.03% gain from current levels.
August 2026
Market indicators suggest Maravai LifeSciences Holdings, Inc. could experience notable changes during August 2026. Prices could fluctuate within $9.84 to $11.89, with a midpoint forecast of $11.07. The stock might deliver a +208.79% gain.
September 2026
Forecasting for September 2026, models estimate that Maravai LifeSciences Holdings, Inc. may undergo key fluctuations. If trends hold, the stock might trade between $10.12 and $13.53, averaging $11.99. This signals a positive trajectory with potential returns around +234.45%.
October 2026
According to our latest forecast models, Maravai LifeSciences Holdings, Inc. (MRVI) is positioned to show a strong performance in October 2026. The price is predicted to move between $10.56 and $14.60, settling at an average of $13.10. This could translate to a +265.41% gain.
November 2026
Based on current market signals, Maravai LifeSciences Holdings, Inc. is projected to trend november 2026. We forecast a trading range from $8.03 to $14.44, with a likely average price of $11.86. Investors could expect a potential return of +230.82%.
December 2026
Our predictive algorithms indicate Maravai LifeSciences Holdings, Inc. stock may see a shift in December 2026. The expected range spans $7.82–$15.91, with an average target of $12.19. This represents a positive outlook and a possible gain of +240.03%.
January 2027
Analyzing established trends, Maravai LifeSciences Holdings, Inc. looks set to move in January 2027. Projections place the stock between $8.59 and $17.45, averaging around $14.61. This suggests a +307.53% gain from current levels.
February 2027
Market indicators suggest Maravai LifeSciences Holdings, Inc. could experience notable changes during February 2027. Prices could fluctuate within $7.01 to $15.34, with a midpoint forecast of $11.76. The stock might deliver a +228.03% gain.
March 2027
Forecasting for March 2027, models estimate that Maravai LifeSciences Holdings, Inc. may undergo key fluctuations. If trends hold, the stock might trade between $7.80 and $18.23, averaging $13.86. This signals a positive trajectory with potential returns around +286.61%.
April 2027
According to our latest forecast models, Maravai LifeSciences Holdings, Inc. (MRVI) is positioned to show a strong performance in April 2027. The price is predicted to move between $5.38 and $18.20, settling at an average of $12.46. This could translate to a +247.56% gain.
MRVI's history of dividends and stock splits also plays a role in long-term investor confidence.